Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Long-Term Investments (2023 - 2025)

Historic Long-Term Investments for Rallybio (RLYB) over the last 3 years, with Q2 2025 value amounting to $626000.0.

  • Rallybio's Long-Term Investments rose 1021.13% to $626000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $626000.0, marking a year-over-year increase of 1021.13%. This contributed to the annual value of $239000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Rallybio reported Long-Term Investments of $626000.0 as of Q2 2025, which was up 1021.13% from $413000.0 recorded in Q1 2025.
  • Rallybio's 5-year Long-Term Investments high stood at $626000.0 for Q2 2025, and its period low was $102000.0 during Q3 2023.
  • Over the past 3 years, Rallybio's median Long-Term Investments value was $358500.0 (recorded in 2024), while the average stood at $362500.0.
  • Per our database at Business Quant, Rallybio's Long-Term Investments soared by 32254.9% in 2024 and then skyrocketed by 1021.13% in 2025.
  • Over the past 3 years, Rallybio's Long-Term Investments (Quarter) stood at $239000.0 in 2023, then soared by 80.33% to $431000.0 in 2024, then skyrocketed by 45.24% to $626000.0 in 2025.
  • Its last three reported values are $626000.0 in Q2 2025, $413000.0 for Q1 2025, and $431000.0 during Q3 2024.